Deerfield Management Company »

Adagene shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Adagene (ADAG) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Adagene

Tip: Access up to 7 years of quarterly data

All positions including Adagene held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagene by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $11M 2.7M 4.20

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Brookdale Sr Living Note 3.500%10/1 (Principal)
Revolution Medicines (RVMD)
Praxis Precision Medicines I Com New (PRAX)
Viatris (VTRS)
Centene Corporation (CNC)
Revolution Medicines Note 0.500% 5/0 (Principal)
United Therapeutics Corporation (UTHR)
Arrowhead Pharmaceuticals In Note 1/1 (Principal)
Legend Biotech Corp Sponsored Ads (LEGN)
Cogent Biosciences (COGT)
Genmab A/s Sponsored Ads (GMAB)
Brookdale Senior Living (BKD)
Vera Therapeutics Cl A (VERA)
Ionis Pharmaceuticals (IONS)

View all positions for Deerfield Management Company

Top funds holding Adagene

Jupiter Topco
Deerfield Management Company
Siren
Ameriprise Financial
Sc China Holding
Squadron Capital Management
Dauntless Investment Group
Citadel Advisors
Exome Asset Management
Birchview Capital
Moneta Group Investment Advisors
Pathstone Holdings
Mill Creek Capital Advisors
Renaissance Technologies
UBS Group

View all funds holding Adagene